Immune-regulatory properties carried by human amnion epithelial cells: Focus on the role of HLA-G and adenosinergic ectoenzymes.

[1]  F. Morandi,et al.  HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies , 2022, International journal of molecular sciences.

[2]  Furong Gao,et al.  Conditioned Medium of Human Amniotic Epithelial Cells Alleviates Experimental Allergic Conjunctivitis Mainly by IL-1ra and IL-10 , 2021, Frontiers in Immunology.

[3]  F. Malavasi,et al.  The Role of Extracellular Vesicles in the Progression of Human Neuroblastoma , 2021, International journal of molecular sciences.

[4]  V. Othenin-Girard,et al.  Mechanisms of Immunomodulation and Cytoprotection Conferred to Pancreatic Islet by Human Amniotic Epithelial Cells , 2021, Stem cell reviews and reports.

[5]  H. Xin,et al.  Characteristics and Therapeutic Potential of Human Amnion-Derived Stem Cells , 2021, International journal of molecular sciences.

[6]  B. Huppertz,et al.  Perinatal Derivatives: Where Do We Stand? A Roadmap of the Human Placenta and Consensus for Tissue and Cell Nomenclature , 2020, Frontiers in Bioengineering and Biotechnology.

[7]  Chao Liu,et al.  A Combination of Lycopene and Human Amniotic Epithelial Cells Can Ameliorate Cognitive Deficits and Suppress Neuroinflammatory Signaling by Choroid Plexus in Alzheimer's disease Rat. , 2020, The Journal of nutritional biochemistry.

[8]  M. Krampera,et al.  Extracellular Vesicle-Dependent Communication Between Mesenchymal Stromal Cells and Immune Effector Cells , 2020, Frontiers in Cell and Developmental Biology.

[9]  S. El-Andaloussi,et al.  Human Amnion Epithelial Cells Impair T Cell Proliferation: The Role of HLA-G and HLA-E Molecules , 2020, Cells.

[10]  Y. Sugita,et al.  Structural and Functional Basis for LILRB Immune Checkpoint Receptor Recognition of HLA-G Isoforms , 2019, The Journal of Immunology.

[11]  R. Gramignoli,et al.  Increased immunomodulatory capacity of human amniotic cells after activation by pro-inflammatory chemokines. , 2019, European journal of pharmacology.

[12]  N. Arsenijević,et al.  Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome , 2019, Cells.

[13]  S. Strom,et al.  Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations , 2018, The Journal of Immunology.

[14]  A. Rezaei,et al.  Immunomodulatory effects of human amniotic epithelial cells on naive CD4+ T cells from women with unexplained recurrent spontaneous abortion. , 2018, Placenta.

[15]  A. Malhotra,et al.  First‐In‐Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study , 2018, Stem cells translational medicine.

[16]  M. Saffari,et al.  The effect of lipopolysaccharide on the expression level of immunomodulatory and immunostimulatory factors of human amniotic epithelial cells , 2018, BMC Research Notes.

[17]  C. Canzonetta,et al.  Canonical and non-canonical adenosinergic pathways. , 2018, Immunology letters.

[18]  C. Figueiredo,et al.  Placenta and Placental Derivatives in Regenerative Therapies: Experimental Studies, History, and Prospects , 2018, Stem cells international.

[19]  Carla F. Kim,et al.  Amnion Epithelial Cell‐Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair , 2018, Stem cells translational medicine.

[20]  Shixia Bu,et al.  Paracrine effects of human amniotic epithelial cells protect against chemotherapy-induced ovarian damage , 2017, Stem Cell Research & Therapy.

[21]  O. Parolini,et al.  The dichotomy of placenta-derived cells in cancer growth. , 2017, Placenta.

[22]  B. Cox,et al.  Cellular analysis of trophoblast and placenta. , 2017, Placenta.

[23]  J. Strominger,et al.  HLA-G: At the Interface of Maternal-Fetal Tolerance. , 2017, Trends in immunology.

[24]  T. Whiteside,et al.  The emerging roles of tumor-derived exosomes in hematological malignancies , 2017, Leukemia.

[25]  S. Strom,et al.  Human amnion epithelial cells expressing HLA-G as novel cell-based treatment for liver disease. , 2016, Human immunology.

[26]  R. Rizzo,et al.  Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases , 2016, Journal of immunology research.

[27]  S. Strom,et al.  Isolation of Human Amnion Epithelial Cells According to Current Good Manufacturing Procedures. , 2016, Current protocols in stem cell biology.

[28]  Zhigang Lu,et al.  Inhibitory leukocyte immunoglobulin-like receptors in cancer development , 2015, Science China Life Sciences.

[29]  O. Parolini,et al.  The Long Path of Human Placenta, and Its Derivatives, in Regenerative Medicine , 2015, Front. Bioeng. Biotechnol..

[30]  C. Locht,et al.  Unconventional, adenosine‐producing suppressor T cells induced by dendritic cells exposed to BPZE1 pertussis vaccine , 2015, Journal of leukocyte biology.

[31]  S. Strom,et al.  Rat-Derived Amniotic Epithelial Cells Differentiate into Mature Hepatocytes In Vivo with No Evidence of Cell Fusion , 2015, Stem cells and development.

[32]  S. Strom,et al.  Translation of amnion stem cells to the clinic. , 2013, Stem cells and development.

[33]  F. Malavasi,et al.  A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes , 2013, Oncoimmunology.

[34]  E. Vizi,et al.  CD39 and CD73 in immunity and inflammation. , 2013, Trends in molecular medicine.

[35]  R. Senetta,et al.  Contribution of adenosine-producing ectoenzymes to the mechanisms underlying the mitigation of maternal-fetal conflicts. , 2013, Journal of biological regulators and homeostatic agents.

[36]  S. Strom,et al.  Placental stem cell correction of murine intermediate maple syrup urine disease , 2013, Hepatology.

[37]  Eric O Long,et al.  KIR2DL4 (CD158d): An activation receptor for HLA-G , 2012, Front. Immun..

[38]  A. Abrantes,et al.  Amniotic membrane: from structure and functions to clinical applications , 2012, Cell and Tissue Research.

[39]  M. Shindoh,et al.  Tumor-Derived Microvesicles Induce Proangiogenic Phenotype in Endothelial Cells via Endocytosis , 2012, PloS one.

[40]  T. Miki.  Amnion-derived stem cells: in quest of clinical applications , 2011, Stem Cell Research & Therapy.

[41]  György Nagy,et al.  Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles , 2011, Cellular and Molecular Life Sciences.

[42]  Aarati R. Ranade,et al.  Hepatic differentiation of amniotic epithelial cells , 2011, Hepatology.

[43]  T. Curiel,et al.  CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. , 2010, Cancer research.

[44]  Shigeo Saito,et al.  Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro , 2008, Human Cell.

[45]  David M. Conrad,et al.  Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). , 2008, International journal of oncology.

[46]  Toshio Miki,et al.  Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells , 2008, Stem cells.

[47]  S. Strom,et al.  Isolation of amniotic epithelial stem cells. , 2007, Current protocols in stem cell biology.

[48]  M. Pera,et al.  Stem Cells Derived from Human Fetal Membranes Display Multilineage Differentiation Potential , 2007, Biology of reproduction.

[49]  Toshio Miki,et al.  Stem Cell Characteristics of Amniotic Epithelial Cells , 2005, Stem cells.

[50]  Toshio Miki,et al.  Use and application of stem cells in toxicology. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[51]  T. Nikaido,et al.  Human Amnion-Isolated Cells Normalize Blood Glucose in Streptozotocin-Induced Diabetic Mice , 2003, Cell Transplantation.

[52]  A. Berrebi,et al.  Soluble HLA‐G: Purification from Eukaryotic Transfected Cells and Detection by a Specific ELISA , 1999, American journal of reproductive immunology.

[53]  Eric O Long,et al.  A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells , 1999, The Journal of experimental medicine.

[54]  T. Ishii,et al.  Evidence for the presence of dopamine D1 receptor mRNA and binding sites in monkey amniotic epithelial cells , 1999, Neuroscience Letters.

[55]  A. McMichael,et al.  Functions of nonclassical MHC and non-MHC-encoded class I molecules. , 1999, Current opinion in immunology.

[56]  K. Lim,et al.  HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. , 1998, Journal of immunology.

[57]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[58]  A. McMichael,et al.  TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide , 1998, Current Biology.

[59]  R. Thangavel,et al.  Evidence for active acetylcholine metabolism in human amniotic epithelial cells: applicable to intracerebral allografting for neurologic disease , 1997, Neuroscience Letters.

[60]  A. Ziegler,et al.  Amnion Epithelial Cells, in Contrast to Trophoblast Cells, Express All Classical HLA Class I Molecules Together With HLA‐G , 1997, American journal of reproductive immunology.

[61]  P. A. Biro,et al.  The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. , 1995, Journal of immunology.

[62]  D. Geraghty,et al.  Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Taillon-Miller,et al.  Cloning and physical mapping of the HLA class I region spanning the HLA-E-to-HLA-F interval by using yeast artificial chromosomes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[64]  S. Fisher,et al.  A class I antigen, HLA-G, expressed in human trophoblasts. , 1990, Science.

[65]  H. Moser,et al.  A therapeutic trial of amniotic epithelial cell implantation in patients with lysosomal storage diseases. , 1985, American journal of medical genetics.

[66]  S. Leibowitz,et al.  IMMUNOGENICITY OF HUMAN AMNIOTIC EPITHELIAL CELLS AFTER TRANSPLANTATION INTO VOLUNTEERS , 1981, The Lancet.

[67]  P. Murthi,et al.  Immunogenicity and immunomodulatory properties of hepatocyte-like cells derived from human amniotic epithelial cells. , 2013, Current stem cell research & therapy.

[68]  Aarati R. Ranade,et al.  Production of hepatocyte-like cells from human amnion. , 2009, Methods in molecular biology.

[69]  S. Strom,et al.  Amnion-derived pluripotent/multipotent stem cells , 2006, Stem Cell Reviews.

[70]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[71]  J. Dausset,et al.  HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. , 2003, Advances in immunology.

[72]  P. Le Bouteiller,et al.  Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: the beginning of a story. , 1996, Research in immunology.